The blood thinner Xarelto® is linked to uncontrolled bleeding.
Approved in 2011, Xarelto® is a new type of blood thinner manufactured by Bayer and marketed in the United States by Johnson & Johnson’s subsidiary, Janssen Pharmaceuticals. It is once-daily pill for atrial fibrillation, a condition that affects about 3 million people in the United States. Xarelto® is prescribed to prevent blood clots that can obstruct the blood flow to vital organs.
Xarelto® Side Effects
Side effects associated with Xarelto include:
• Intestinal Bleeding
• Brain Hemorrhaging
• Internal Bleeding
• Heart Attack
• Gastrointestinal Bleeding
• Blood Clots
When bleeding occurs near a major organ, blood flow to that organ is interrupted, causing it to lose some or all of its functionality. Pools of blood may form within the body that can cause other dangerous health risks, and because Xarelto® prevents clotting, bleeding will continue until the drug is out of the system.
Xarelto® is considered a high-risk prescription drug because it can cause excessive internal bleeding among other injuries in patients. While all blood thinners have the risk of internal bleeding, older drugs have emergency antidotes to prevent serious injury. Xarelto® does not have an antidote.
The content on this web page is for informational purposes only.